What is the tapering dose of lorazepam (Ativan) for alcohol withdrawal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lorazepam Tapering for Alcohol Withdrawal

Start lorazepam at 6-12 mg/day divided into doses of 1-4 mg every 4-8 hours, then taper gradually following resolution of withdrawal symptoms. 1

Initial Dosing Strategy

Lorazepam is specifically recommended for patients with severe alcohol withdrawal syndrome (AWS), advanced age, recent head trauma, liver failure, respiratory failure, other serious medical comorbidities, or obesity. 1 This is because lorazepam undergoes direct glucuronidation without hepatic metabolism, making it safer in hepatic dysfunction compared to long-acting benzodiazepines like chlordiazepoxide or diazepam. 2

Starting Dose

  • Begin with 6-12 mg/day total, divided into 1-4 mg doses every 4-8 hours 1
  • The FDA label indicates the usual anxiety range is 2-6 mg/day, but alcohol withdrawal requires higher initial dosing 3
  • For severe withdrawal, use the higher end of this range 1

Tapering Protocol

The taper should begin once withdrawal symptoms resolve, with gradual dose reduction to minimize withdrawal reactions. 1, 3

Structured Taper Approach

  • Fixed-dose tapering regimen: Start at 6-8 mg/day on day 1, tapering to 2 mg/day by day 4-5 4, 5
  • Symptom-triggered approach is superior: This method uses significantly less total medication (mean 9.5 mg vs 19.9 mg) over a shorter duration (47.8 hours vs 146 hours) compared to fixed-dose regimens, with equal safety 6
  • Increase evening doses before daytime doses when higher dosing is needed 3
  • If withdrawal reactions develop during taper, pause the taper or increase back to the previous dose level, then decrease more slowly 3

Monitoring Requirements

Use CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol) scores to guide treatment intensity, though it should not be used alone for diagnosis. 1, 2

Assessment Parameters

  • CIWA-Ar score >8 indicates moderate withdrawal; ≥15 indicates severe withdrawal 2
  • Monitor vital signs, mental status, and withdrawal symptoms regularly 2
  • Symptom-triggered regimens prevent medication accumulation and are preferred over fixed schedules 2, 6

Critical Adjunctive Treatment

Thiamine 100-300 mg/day must be given to ALL patients with alcohol withdrawal syndrome before any glucose-containing fluids to prevent Wernicke encephalopathy. 1, 2, 7 This is non-negotiable as IV glucose can precipitate acute thiamine deficiency. 2, 7

Additional Supportive Care

  • Ensure adequate hydration and electrolyte replacement, especially magnesium 2
  • Continue thiamine for 2-3 months following resolution of withdrawal symptoms 1

Duration Considerations

Avoid benzodiazepine use beyond 10-14 days due to abuse potential. 2 The typical alcohol withdrawal taper is completed within 4-8 days. 4, 5

Common Pitfalls

  • Do not use lorazepam as first-line in uncomplicated withdrawal with normal liver function: Long-acting benzodiazepines (chlordiazepoxide, diazepam) provide better seizure protection in standard cases 1
  • Lorazepam-treated patients may experience rebound withdrawal symptoms post-treatment: This occurred significantly more with lorazepam than carbamazepine in one study 4
  • 20% of lorazepam-treated patients experienced dizziness, motor incoordination, or ataxia without recognizing their impairment 4
  • Abrupt discontinuation increases seizure and delirium tremens risk: Always use gradual tapering 3

Inpatient vs Outpatient Decision

Admit patients with serious complications (delirium, seizures), significant medical/psychiatric comorbidities, history of withdrawal seizures or delirium tremens, high levels of recent drinking, or failed outpatient treatment. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Mild Alcohol Withdrawal

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Alcohol Dependence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.